FIELD: medicine.
SUBSTANCE: invention represents a method for assessing long-term hyperglycemia based on measuring blood plasma glucose differing by the fact that glucose is measured twice: immediately after blood taking and 24 hours after blood plasma storage above a layer of blood corpuscles; that is followed by calculating a glucose reduction in percentage from the initial value which is used to assess long-term hyperglycemia with blood plasma stored at t=4.0±0.5°C.
EFFECT: invention provides optimising and reducing assessment time of long-term hyperglycemia, more reliable result and possibility to examine a maximum amount of individuals over a minimum period of time and detecting a risk group.
2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SIMULATING ALLOXAN DIABETES | 2013 |
|
RU2534411C1 |
| USE OF COMPOUNDS OF 1,3,4-THIADIAZINE CLASS AS AGENT FOR CORRECTION OF EXPERIMENTAL ALLOXAN DIABETES | 2014 |
|
RU2597764C2 |
| APPLICATION OF PHARMACEUTICAL COMPOSITION OF 2-MORPHOLINO-5-PHENYL-6H-1,3,4-THIADIAZINE WITH ASCORBIC ACID AS MEANS FOR ALLOXAN DIABETES CORRECTION | 2016 |
|
RU2626677C1 |
| DIAGNOSTIC TECHNIQUE FOR DIABETES MELLITUS BY MEASURING ERYTHROCYTE CU,ZN-SUPEROXIDE DISMUTASE ACTIVITY | 2014 |
|
RU2569750C1 |
| ANTIDIABETIC AGENT WITH HYPOLIPIDEMIC ACTIVITY FOR TREATMENT AND PREVENTION OF INSULAR DIABETES II TYPE | 2007 |
|
RU2337698C1 |
| HERBAL MEDICINAL PRODUCT HAVING ENDOTHELIOPROTECTIVE ACTIVITY | 2014 |
|
RU2561064C1 |
| METHOD OF DIAGNOSIS OF DIABETES DECOMPENSATION | 0 |
|
SU1772747A1 |
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION IN CARBOHYDRATE METABOLISM DISORDERS ACCOMPANIED BY END-STAGE INSULIN DEFICIENCY | 2020 |
|
RU2751414C1 |
| MATERIALS AND METHOD FOR MODULATION OF PROLIFERATION AND DIFFERENTIATION OF REGULATORY, STEM AND OTHER SOMATIC CELLS | 2014 |
|
RU2620069C2 |
| METHOD FOR PROGNOSTICATION OF DIABETES MELLITUS COMPLICATIONS IN CHILDREN | 0 |
|
SU1640655A1 |
